Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
Trial Type: Melanoma and Skin Cancers
LS-P-HAT
A Phase 1 Study of NM32-2668 (Anti ROR1/Anti CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors
Status: Open
Trial Type:
Breast Cancer
,
Early Phase Trials for Multiple Cancer Types
,
Esophageal Cancer
,
Gastric Cancer
,
Kidney and Bladder Cancer
,
Lung Cancer
,
Melanoma and Skin Cancers
,
Ovarian Cancer
,
Soft Tissue and Bone Cancer
,
Uterine Cancer
Contact: Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org
BrUOG 416
Phase I and II Study of NovoTTF-200A and Pembrolizumab in Newly Diagnosed Melanoma Brain Metastasis
Status: Open
Trial Type:
Melanoma and Skin Cancers
Contact: Dr. Maria Constantinou
mconstantinou@lifespan.org
HEAT Trial
Bifunctional antibody against EGFR and TGF Beta, alone and in combination with pembrolizumab for Head and neck cancer, NSCLC and anal cancer and cutaneous squamous cell cancer
Status: Open
Trial Type:
Early Phase Trials for Multiple Cancer Types
,
Head and Neck Cancer
,
Lung Cancer
,
Melanoma and Skin Cancers
Contact: Dr. Ari Birnbaum
abirnbaum@lifespan.org